ArticleCancers2023

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.

Francesca R Mauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.